Fertility and Sterility
Volume 91, Issue 6 , Pages 2419-2425, June 2009

Serum inhibin B during controlled ovarian hyperstimulation: an additional criterion for deciding whether to proceed with egg retrieval

  • Christine Decanter, M.D.

      Affiliations

    • Department of Endocrine Gynecology and Reproductive Medicine, Hôpital Jeanne de Flandre, Centre Hospitalier Régional Universitaire (CHRU), Lille, France
    • Faculty of Medicine, Université de Lille II, Lille, France
    • Corresponding Author InformationReprint requests: Christine Decanter, M.D., Department of Endocrine Gynecology and Reproductive Medicine, Hôpital Jeanne de Flandre, CHRU, 59037 Lille, France (FAX: 33-3-20-44-41-84).
  • ,
  • Pascal Pigny, M.D.

      Affiliations

    • Laboratory of Endocrinology, Parc Eurasante, CHRU, Lille, France
  • ,
  • Catherine Lefebvre, M.D.

      Affiliations

    • Department of Endocrine Gynecology and Reproductive Medicine, Hôpital Jeanne de Flandre, Centre Hospitalier Régional Universitaire (CHRU), Lille, France
    • Faculty of Medicine, Université de Lille II, Lille, France
  • ,
  • Patricia Thomas, M.D.

      Affiliations

    • Department of Endocrine Gynecology and Reproductive Medicine, Hôpital Jeanne de Flandre, Centre Hospitalier Régional Universitaire (CHRU), Lille, France
    • Faculty of Medicine, Université de Lille II, Lille, France
  • ,
  • Maryse Leroy, M.D.

      Affiliations

    • Department of Endocrine Gynecology and Reproductive Medicine, Hôpital Jeanne de Flandre, Centre Hospitalier Régional Universitaire (CHRU), Lille, France
    • Faculty of Medicine, Université de Lille II, Lille, France
  • ,
  • Didier Dewailly, M.D.

      Affiliations

    • Department of Endocrine Gynecology and Reproductive Medicine, Hôpital Jeanne de Flandre, Centre Hospitalier Régional Universitaire (CHRU), Lille, France
    • Faculty of Medicine, Université de Lille II, Lille, France

Received 10 January 2008; received in revised form 13 March 2008; accepted 14 March 2008. published online 13 June 2008.

Objective

To determine the predictive value of the inhibin B increment during controlled ovarian hyperstimulation (COH) for differentiating between poor and normal responders and for deciding whether to continue or stop an IVF attempt.

Design

Prospective study.

Setting

Assisted reproduction unit at a university hospital.

Patient(s)

A total of 110 women undergoing IVF for idiopathic, tubal, and/or male infertility.

Intervention(s)

Blood samples were collected on days 6 and 8 of COH. Inhibin B and E2 assays were performed.

Main Outcomes Measure(s)

The degree of inhibin B increment was defined as ΔIB = day-8 value minus day-6 value. We analyzed the correlation of day-6 and day-8 inhibin B values and ΔIB with the number of oocytes retrieved. The predictive value of each parameter was determined by using the receiving operator characteristics curve analysis.

Result(s)

The ΔIB correlated best with the number of oocytes retrieved (r = 0.5) and with the number of embryos obtained (r = 0.26), independently of age. From the receiving operator characteristics curve analysis, a ΔIB cutoff value of 300 pg/mL discriminated poor (few than four oocytes retrieved, n = 16) from normal (more than four oocytes retrieved, n = 94) responders, with a sensitivity of 70% and a specificity of 94%.

Conclusion(s)

The degree of inhibin B increment during COH provides additional information for predicting ovarian response to COH. An increment >300 pg/mL is required to rule out the eventuality of a poor ovarian response.

Key Words: Oocytes, dynamic inhibin B, poor responders, IVF outcome, ovarian response

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 C.D. has nothing to disclose. P.P. has nothing to disclose. C.L. has nothing to disclose. P.T. has nothing to disclose. M.L. has nothing to disclose. D.D. has nothing to disclose.

PII: S0015-0282(08)00704-8

doi:10.1016/j.fertnstert.2008.03.037

Fertility and Sterility
Volume 91, Issue 6 , Pages 2419-2425, June 2009